AHL Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-13,084
| Closed | -$1.11M | – | 1310 |
|
|
2017
Q3 | $1.11M | Buy |
13,084
+7,230
| +124% | +$614K | 0.02% | 848 |
|
|
2017
Q2 | $443K | Buy |
+5,854
| New | +$443K | 0.01% | 955 |
|
|
2016
Q1 | – | Sell |
-30,927
| Closed | -$2.09M | – | 796 |
|
|
2015
Q4 | $2.09M | Buy |
30,927
+24,236
| +362% | +$1.64M | 0.16% | 239 |
|
|
2015
Q3 | $358K | Sell |
6,691
-69,123
| -91% | -$3.7M | 0.06% | 502 |
|
|
2015
Q2 | $4.77M | Buy |
+75,814
| New | +$4.77M | 0.19% | 201 |
|